biologics

Paradigm Shifts in Lab Monitoring
Lab Monitoring
by Edita Newton, MD on
How to Mitigate Risk without Compromising Care If you were to counsel a patient on every possible risk of a given medication, it would be a long list of extreme and rare potential outcomes and almost certainly leave the patient in doubt whether it is safe even to take. Frequent lab monitoring has been common practice and often used to reduce the perception of risk with systemic medication …
Easing the Management of Atopic Dermatitis
Atopic Dermatitis
by Jacqueline McKesey, MD MS on
Dr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
Treatment of Hidradenitis Suppurativa in 2021 & Beyond
Treatment of Hidradenitis Suppurativa
by Blair Allais, MD on
At the ODAC 2021 Sneak Peek Symposium on Inflammatory Skin Diseases, expert faculty presented on the topics of acne, rosacea, atopic dermatitis, hidradenitis suppurativa, and psoriasis. If you missed the live symposium, Next Steps will be sharing highlights and a summary of each lecture over the course of the next few weeks. Today, Dr. Blari Allais shares an excellent recap of Dr. Joslyn Kirby's s …
COVID-19 News & Resource Center
COVID-19 News & Resources
by NEXT STEPS IN DERM TEAM on
[vc_row][vc_column][vc_column_text]EPI Health has graciously supported the COVID-19 News and Resource Center. COVID-19 DERM TOPICS COVID-19 Peer-reviewed Articles Safely Reopening Derm Practices Video Series JDD COVID-19 Webinar Series COVID-19: Urgent Medical and Aesthetic Issues for Dermatology Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provi …
Tumor Necrosis Factor (TNF) Inhibitors Therapeutic Cheat Sheet
TNF inhibitors for psoriasis
by Jessica Kalen, MD on
With the advent of biologics, patients with moderate-to-severe plaque psoriasis have experienced increased control of disease and improved quality of life. Tumor necrosis factor (TNF) inhibitors are some of the earliest biologics prescribed for psoriasis, psoriatic arthritis and, more recently, hidradenitis suppurativa. In this month’s installment of Therapeutic Cheat Sheets, we discuss TNF inhi …